<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02368561</url>
  </required_header>
  <id_info>
    <org_study_id>MMC140082CTIL</org_study_id>
    <nct_id>NCT02368561</nct_id>
  </id_info>
  <brief_title>Treatment of Insertional Achilles Tendinopathy by Hyaluronic Acid Injection</brief_title>
  <official_title>A Pilot Study of the Effects of 3 Retro-calcaneal Hyalin G-F 20 Injection on the Clinical and Radiological Changes in 20 Adult Patients With Changes in Insertional Achilles Tendinopathy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pilot study of the effects of 3 retro-calcaneal hyalin G-F 20 injection on the clinical and
      radiological changes in 20 adult patients with changes in insertional achilles tendinopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain of the achilles tendon commonly affects young active patients, with lifetime incidence
      that may be as high as 40 to 50 percent in competitive athletes. About 20% of the achilles
      tendinopathy injuries occur in the insertion point of the achilles tendon into the calcaneus
      bone1. The leading theories for the mechanism of the disorder are inflammatory response or
      mechanical tendon overuse. Still, the exact pathogenesis of Insertional Achilles tendinitis
      (IAT) is unclear, and as so the conservative management of IAT is less successful than the
      management of the Non-insertional tendinopathy. Previous histological description, in an
      unpublished data of the insertion point showed that the main pathologic features were found
      to be in the bone and cartilage tissues. The achilles tendon, in those studies, was almost
      intact. The histological features of the cartilage tissue were advanced degenerative changes,
      which resemble the pathologic changes of Osteoarthritis. This observation encourages to try
      treating IAT with management strategies that showed to be beneficial in OA( OsteoArthritis).
      One of the more acceptable non-surgical methods in treating osteoarthritis is intra-articular
      viscosupplementation injection. The investigators hypothesis, based on the histopathological
      finding, is that viscosupplementation may be a therapeutic option also for individuals with
      IAT. The purpose of this study is to show the impact of Hyalin G-F 20 injection in patients
      with Insertional Achilles tendinitis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the VISA-A questionnaire score</measure>
    <time_frame>Change in the VISA-A questionnaire score during 6 months follow-up</time_frame>
    <description>The VISA-A questionnaire score at 3 points during the follow-up: before the treatment, one month after the procedure and 6 months from the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The sonographic signs</measure>
    <time_frame>Change in the achilles tendinosis sonographic signs during 6 months follow-up</time_frame>
    <description>The sonographic signs in the achilles enthesis- hypoechoic swelling, hyperemia, peritendinitis, fluid in the retrocalcaneal bursa, osseous prominence at the posterosuperior calcaneus.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Insertional Achilles Tendinitis</condition>
  <arm_group>
    <arm_group_label>Hyaluronic Acid Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyaluronic Acid Injection in 20 adult patients with IAT</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Injection of Hyaluronic Acid -&quot; SYNVISC&quot; (hylan G-F 20)</intervention_name>
    <description>US guided weekly injection of sodium hyaluronate administered for 3 week in adult subjects with insertional achilles tendinopathy</description>
    <arm_group_label>Hyaluronic Acid Injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with chronic (&gt;6 months) posterior heel pain localized above the
             insertion point of the achilles tendon with evidence of IAT in ankle X-RAY and MRI.

        Exclusion Criteria:

          1. Previous surgical treatment.

          2. Previous HA(Hyaluronic Acid), PRP (Platelet Rich Plasma) or steroids injection in the
             last 6 months.

          3. Previous two or more steroids injection.

          4. Plantaris muscle injury.

          5. Posterior ankle impingement.

          6. Achilles tendon rapture.

          7. Previous calcaneal fracture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meir Nyska, Prop</last_name>
    <role>Study Director</role>
    <affiliation>head of orthopedic department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ezequiel Palmanovich, Dr</last_name>
    <phone>972-5250868</phone>
    <email>ezepalm@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Omer Slevin, Dr</last_name>
    <phone>972-54556306</phone>
    <email>Omerslevin@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Roche AJ, Calder JD. Achilles tendinopathy: A review of the current concepts of treatment. Bone Joint J. 2013 Oct;95-B(10):1299-307. doi: 10.1302/0301-620X.95B10.31881. Review.</citation>
    <PMID>24078523</PMID>
  </reference>
  <reference>
    <citation>Wiegerinck JI, Kerkhoffs GM, van Sterkenburg MN, Sierevelt IN, van Dijk CN. Treatment for insertional Achilles tendinopathy: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2013 Jun;21(6):1345-55. doi: 10.1007/s00167-012-2219-8. Epub 2012 Oct 6. Review.</citation>
    <PMID>23052113</PMID>
  </reference>
  <reference>
    <citation>Oshri Y, Palmanovich E, Brin YS, Karpf R, Massarwe S, Kish B, Nyska M. Chronic insertional Achilles tendinopathy: surgical outcomes. Muscles Ligaments Tendons J. 2012 Sep 10;2(2):91-5. Print 2012 Apr.</citation>
    <PMID>23738280</PMID>
  </reference>
  <reference>
    <citation>Irwin TA. Current concepts review: insertional achilles tendinopathy. Foot Ankle Int. 2010 Oct;31(10):933-9. doi: 10.3113/FAI.2010.0933. Review.</citation>
    <PMID>20964977</PMID>
  </reference>
  <reference>
    <citation>Kearney R, Costa ML. Insertional achilles tendinopathy management: a systematic review. Foot Ankle Int. 2010 Aug;31(8):689-94. doi: 10.3113/FAI.2010.0689. Review.</citation>
    <PMID>20727317</PMID>
  </reference>
  <reference>
    <citation>Petrou MJ. Re: Kuipers H, Ruijsch van Dugteren G. Letter to the editors - the prohibited list and cheating in sport. Int J Sports Med 2006; 27: 80 - 82. Int J Sports Med. 2006 Jan;27(1):83-4.</citation>
    <PMID>16388448</PMID>
  </reference>
  <reference>
    <citation>Kumai T, Muneta T, Tsuchiya A, Shiraishi M, Ishizaki Y, Sugimoto K, Samoto N, Isomoto S, Tanaka Y, Takakura Y. The short-term effect after a single injection of high-molecular-weight hyaluronic acid in patients with enthesopathies (lateral epicondylitis, patellar tendinopathy, insertional Achilles tendinopathy, and plantar fasciitis): a preliminary study. J Orthop Sci. 2014 Jul;19(4):603-11. doi: 10.1007/s00776-014-0579-2. Epub 2014 May 10.</citation>
    <PMID>24817495</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2015</study_first_submitted>
  <study_first_submitted_qc>February 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2015</study_first_posted>
  <last_update_submitted>February 16, 2015</last_update_submitted>
  <last_update_submitted_qc>February 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Hylan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

